Jeonghun Lee

Dr. Jeonghun Lee

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2013 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
JLJeonghun Lee
Jeonghun Lee
YSYoungpeck Song
Youngpeck Song
ESEuy Young Soh
Euy Young Soh

1 January 2014 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JLJeonghun Lee
Jeonghun Lee
YSYeongpeck Song
Yeongpeck Song
ESEuy Young Soh
Euy Young Soh
Lee J, et al. J Korean Med Sci. 2014 Jan;29(1):48-52. http://dx.doi.org/10.3346/jkms.2014.29.1.48

8 January 2020 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
ILInhwa Lee
Inhwa Lee
HKHyeung Kyoo Kim
Hyeung Kyoo Kim
ESEuy Young Soh
Euy Young Soh
JLJeonghun Lee
Jeonghun Lee

1 January 2022 in Ultrasonography
Verified
Journal Article
Open access
PDF file
SJSo Yeong Jeong
So Yeong Jeong
EHEun Ju Ha
Eun Ju Ha
JBJung Hwan Baek
Jung Hwan Baek
TKTae Hyuk Kim
Tae Hyuk Kim
YLYu-mi Lee
Yu-mi Lee
JLJeonghun Lee
Jeonghun Lee
Purpose: Radiofrequency ablation (RFA) and ethanol ablation (EA) are effective and safe for benign symptomatic thyroid nodules (BSTNs). However, relatively little is known about the effects of these procedures on patients’ quality of life (QoL). This prospective, multicenter study evaluated the effects of RFA and EA on changes in thyroid-specific QoL in patients with BSTNs and assessed the volume reduction and safety of these procedures.Methods: Eighty-six consecutive patients with 86 BSTNs were prospectively included from two medical centers. RFA was performed for 55 BSTNs with solidity ≥50% and EA was performed for 31 BSTNs with solidity <50%. QoL was evaluated using an 11-scale, multiple-choice thyroid-specific QoL questionnaire. Nodule characteristics and QoL were evaluated at diagnosis and 1, 6, and 12 months after treatment. Overall QoL was rated from 0 (good) to 4 (poor).Results: The mean longest size and volume of the index nodule were 4.2±1.5 cm and 21.6±22.1 mL, respectively. Patients received 1.1 treatments on average (range, 1 to 2). Significant post-treatment volume reductions were noted; however, the EA group showed a higher volume reduction than the RFA group at 1 (78.7%-16.1% vs. 49.1%-15.8%), 6 (86.3%-21.7% vs. 73.0%-14.5%), and 12 (90.9%-14.9% vs. 80.3%-12.4%) months. The score for each scale of the QoL questionnaire improved significantly during follow-up (all P<0.001). Overall QoL improved significantly, 1.7±0.9 at diagnosis to 0.6±0.7 at the 12-month follow-up (P<0.001). There were no major complications.Conclusion: Both RFA and EA are safe and effective in reducing nodule volume and improving thyroid-specific QoL in patients with BSTNs.

7 May 2013 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
SYShin-Young Yim
Shin-Young Yim
DYDukyong Yoon
Dukyong Yoon
MPMyong Chul Park
Myong Chul Park
ILIl Jae Lee
Il Jae Lee
JKJang-Hee Kim
Jang-Hee Kim
JJJae-Bum Jun
Jae-Bum Jun
Congenital muscular torticollis (CMT) is characterized by thickening and/or tightness of the unilateral sternocleidomastoid muscle (SCM), ending up with torticollis. Our aim was to identify differentially expressed genes (DEGs) and novel protein interaction network modules of CMT, and to discover the relationship between gene expressions and clinical severity of CMT.

1 January 2017 in Journal of Endocrine Surgery
Verified
Journal Article
Open access
PDF file
SKSu Jung Kim
Su Jung Kim
JLJeonghun Lee
Jeonghun Lee
ESEuy Young Soh
Euy Young Soh
Kim SJ, et al. J Endocr Surg. 2017 Dec;17(4):175-183. https://doi.org/10.16956/jes.2017.17.4.175